Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed)
The purpose of the Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) Funding Opportunity Announcement (FOA) is to facilitate the translation of vaccine candidates into early clinical testing.
The IPCAVD program is designed to enable a multi-disciplinary team to complete
necessary steps from final down-selection of an advanced vaccine candidate through regulatory submissions needed for clinical trial(s).
These steps include technology transfer, process development, optimization, assay development and qualification, analytical testing, cGMP manufacture, quality assurance oversight, safety testing, product release, drug substance and drug product stability testing program, IND-enabling studies, and regulatory submissions.
This FOA will not provide funds for conducting the clinical studies; applicants are encouraged to collaborate with NIAID-supported clinical trial networks or to develop other relationships to support the clinical studies.
The IPCAVD program is designed to enable a multi-disciplinary team to complete
necessary steps from final down-selection of an advanced vaccine candidate through regulatory submissions needed for clinical trial(s).
These steps include technology transfer, process development, optimization, assay development and qualification, analytical testing, cGMP manufacture, quality assurance oversight, safety testing, product release, drug substance and drug product stability testing program, IND-enabling studies, and regulatory submissions.
This FOA will not provide funds for conducting the clinical studies; applicants are encouraged to collaborate with NIAID-supported clinical trial networks or to develop other relationships to support the clinical studies.
Related Programs
Allergy, Immunology and Transplantation Research
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: $5,000,000
Office: National Institutes of Health
Estimated Funding: $5,000,000
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PAR-20-120.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/pa-files/PAR-20-120.html
Contact:
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
Date Posted:
2020-03-03
Application Due Date:
Archive Date:
2022-04-14
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Learn How to Identify and Avoid Grant Scams
